Literature DB >> 9733784

Phosphorylation of vitronectin by casein kinase II. Identification of the sites and their promotion of cell adhesion and spreading.

D Seger1, Z Gechtman, S Shaltiel.   

Abstract

The cell adhesion protein vitronectin (Vn) was previously shown to be the major target in human blood for an extracellular protein kinase A, which is released from platelets upon their physiological stimulation with thrombin and also prevails as an ectoenzyme in several other types of blood cells. Because plasma Vn was shown to have only one protein kinase A phosphorylation site (Ser378) but to contain approximately 3 mol of covalently bound phosphate, and because human serum and blood cells were shown to contain also a casein kinase II (CKII) on their surface, we studied the phosphorylation of Vn by CKII attempting to find out whether such phosphorylation modulates Vn function, an acid test for its having a physiological relevance. Here we show (i) that the CKII phosphorylation of Vn has a Km of 0.5-2 microM (lower than the Vn concentration in blood, 3-6 microM), (ii) that it is targeted to Thr50 and Thr57, which are vicinal to the RGD site of Vn, and (iii) that the phosphorylation of Thr57 facilitates the phosphorylation of Thr50. The maximal stoichiometry of the CKII phosphorylation of plasma Vn was found to be low, which, in principle, could be due to its partial prephosphorylation in vivo. However, for the detection of a functional modulation, we needed a comparison between a fully phosphorylated Vn (at Thr57 and Thr50) and a nonphosphorylated Vn. Therefore, we expressed Vn in a baculovirus system and show (i) that the CKII phosphorylation of wt-Vn enhances the adhesion of bovine aorta endothelial cells; (ii) that the double mutant T50E/T57E (in which the neutral Thr residues are replaced by the negatively charged Glu residues considered analogs of Thr-P) has a significantly enhanced capacity to promote cell adhesion and to accelerate cell spreading when compared with either wild-type Vn or to the neutral T50A/T57A mutant; and (iii) that, at least in the case of bovine aorta endothelial cells, the T50E/T57E mutant exhibits an enhanced adhesion, which seems to be due to an increased affinity toward the alphav beta3 Vn receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733784     DOI: 10.1074/jbc.273.38.24805

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Protein kinase casein kinase 2 holoenzyme produced ectopically in human cells can be exported to the external side of the cellular membrane.

Authors:  Fernando Rodríguez; Catherine C Allende; Jorge E Allende
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-17       Impact factor: 11.205

2.  Phosphorylation mapping of Laminin β1-chain: Kinases in association with active sites.

Authors:  Kleio-Maria Verrou; Panagiota Angeliki Galliou; Maria Papaioannou; Georgios Koliakos
Journal:  J Biosci       Date:  2019-06       Impact factor: 1.826

Review 3.  Ecto-protein kinase CK2, the neglected form of CK2.

Authors:  Mathias Montenarh; Claudia Götz
Journal:  Biomed Rep       Date:  2018-02-21

Review 4.  CK2 and the Hallmarks of Cancer.

Authors:  May-Britt Firnau; Angela Brieger
Journal:  Biomedicines       Date:  2022-08-16

5.  Neisseria meningitidis Opc invasin binds to the sulphated tyrosines of activated vitronectin to attach to and invade human brain endothelial cells.

Authors:  Claudia Sa E Cunha; Natalie J Griffiths; Mumtaz Virji
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

6.  Protein kinase CK2 and cell polarity.

Authors:  Alexandre Deshière; Nathalie Theis-Febvre; Véronique Martel; Claude Cochet; Odile Filhol
Journal:  Mol Cell Biochem       Date:  2008-06-28       Impact factor: 3.396

7.  A deletion mutant of vitronectin lacking the somatomedin B domain exhibits residual plasminogen activator inhibitor-1-binding activity.

Authors:  Christine R Schar; Grant E Blouse; Kenneth H Minor; Cynthia B Peterson
Journal:  J Biol Chem       Date:  2008-01-03       Impact factor: 5.157

Review 8.  Proteomic database mining opens up avenues utilizing extracellular protein phosphorylation for novel therapeutic applications.

Authors:  Garif Yalak; Bjorn R Olsen
Journal:  J Transl Med       Date:  2015-04-19       Impact factor: 5.531

9.  Ecto-protein kinases and phosphatases: an emerging field for translational medicine.

Authors:  Garif Yalak; Yigal H Ehrlich; Bjorn R Olsen
Journal:  J Transl Med       Date:  2014-06-12       Impact factor: 5.531

Review 10.  The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System.

Authors:  Oskar Eriksson; Camilla Mohlin; Bo Nilsson; Kristina N Ekdahl
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.